학술논문
Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): a single-arm, multicentre, phase 2 trial
Document Type
Article
Author
Albiges, Laurence ; Gurney, Howard; Atduev, Vagif; Suarez, Cristina; Climent, Miguel A; Pook, David; Tomczak, Piotr; Barthelemy, Philippe; Lee, Jae Lyun; Stus, Viktor; Ferguson, Thomas; Wiechno, Pawel; Gokmen, Erhan; Lacombe, Louis; Gedye, Craig; Perini, Rodolfo F; Sharma, Manish; Peng, Xiang; Lee, Chung-Han
Source
In The Lancet Oncology August 2023 24(8):881-891
Subject
Language
ISSN
1470-2045